Last Updated: June 8, 2026

Claims for Patent: 11,267,893

✉ Email this page to a colleague

Summary for Patent: 11,267,893

Title:	Anti-IL36R antibodies
Abstract:	The present invention provides antibodies and antigen-binding fragments (e.g., human antibodies) that bind specifically to human Interleukin-36 receptor (IL36R). Methods for treating or preventing diseases mediated by IL36R (e.g., skin or colon inflammatory conditions such as palmo-plantar pustular psoriasis, palmoplantar pustulosis, generalized pustular psoriasis, ulcerative colitis or IBD) using the antibodies and fragments are also provided along with methods of making the antibodies and fragments.
Inventor(s):	Fairhurst Jeanette, Garnova Elena, Olson William, Haxhinasto Sokol
Assignee:	Regeneron Pharmaceuticals, Inc.
Application Number:	US16512886
Patent Claims:

Details for Patent 11,267,893

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	REMICADE	infliximab	For Injection	103772	August 24, 1998	11,267,893	2039-07-16
Immunex Corporation	ENBREL	etanercept	For Injection	103795	November 02, 1998	11,267,893	2039-07-16
Immunex Corporation	ENBREL	etanercept	For Injection	103795	May 27, 1999	11,267,893	2039-07-16
Immunex Corporation	ENBREL	etanercept	Injection	103795	September 27, 2004	11,267,893	2039-07-16
Immunex Corporation	ENBREL	etanercept	Injection	103795	February 01, 2007	11,267,893	2039-07-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.